These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 33563580)
1. Fixed-Dose Glucarpidase for Toxic Methotrexate Levels and Acute Kidney Injury in Adult Lymphoma Patients: Case Series. Truong H; Leung N Clin Lymphoma Myeloma Leuk; 2021 Jun; 21(6):e497-e502. PubMed ID: 33563580 [No Abstract] [Full Text] [Related]
2. Comparable efficacy with varying dosages of glucarpidase in pediatric oncology patients. Scott JR; Zhou Y; Cheng C; Ward DA; Swanson HD; Molinelli AR; Stewart CF; Navid F; Jeha S; Relling MV; Crews KR Pediatr Blood Cancer; 2015 Sep; 62(9):1518-22. PubMed ID: 25631103 [TBL] [Abstract][Full Text] [Related]
3. A second administration of glucarpidase in a different cycle of high-dose methotrexate: Is it safe and effective in adults? Domingo-González A; Osorio S; Landete E; Monsalvo S; Díez-Martín JL J Oncol Pharm Pract; 2021 Apr; 27(3):734-738. PubMed ID: 32731844 [TBL] [Abstract][Full Text] [Related]
4. Rechallenge With High-Dose Methotrexate After Treatment With Glucarpidase in Adult Patients With Lymphoma. Truong HL; Barreto JN; Mara KC; Hampel PJ; Micallef IN; Nowakowski GS; Thanarajasingam G; Thompson CA; Wang Y; Witzig TE; Herrmann SM; Leung N JCO Oncol Pract; 2024 Jun; 20(6):797-807. PubMed ID: 38408299 [TBL] [Abstract][Full Text] [Related]
5. Using a lower dose of glucarpidase to reduce plasma levels of methotrexate. Widemann BC Clin Adv Hematol Oncol; 2013 May; 11(5):324-5. PubMed ID: 23880720 [No Abstract] [Full Text] [Related]
6. Reduced-dose carboxypeptidase-G2 successfully lowers elevated methotrexate levels in an adult with acute methotrexate-induced renal failure. Trifilio S; Ma S; Petrich A Clin Adv Hematol Oncol; 2013 May; 11(5):322-3. PubMed ID: 23880719 [No Abstract] [Full Text] [Related]
7. Half-dose glucarpidase as efficient rescue for toxic methotrexate levels in patients with acute kidney injury. Heuschkel S; Kretschmann T; Teipel R; von Bonin S; Richter S; Quick S; Alakel N; Röllig C; Balaian E; Kroschinsky F; Knoth H; Bornhäuser M; von Bonin M Cancer Chemother Pharmacol; 2022 Jan; 89(1):41-48. PubMed ID: 34669022 [TBL] [Abstract][Full Text] [Related]
8. Reply to: Glucarpidase for the Treatment of Methotrexate-Induced Renal Dysfunction and Delayed Methotrexate Excretion. Widemann BC Pediatr Blood Cancer; 2016 Feb; 63(2):366. PubMed ID: 26488622 [No Abstract] [Full Text] [Related]
9. Delayed Methotrexate Clearance Despite Carboxypeptidase-G2 (Glucarpidase) Administration in 2 Patients With Toxic Methotrexate Levels. Wyatt KD; Cooper J; Scott K; Broomall E; Altaf S; Hogan MC; Rodriguez V; Khan S J Pediatr Hematol Oncol; 2018 Mar; 40(2):152-155. PubMed ID: 29240024 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of glucarpidase (carboxypeptidase g2) in patients with acute kidney injury after high-dose methotrexate therapy. Widemann BC; Schwartz S; Jayaprakash N; Christensen R; Pui CH; Chauhan N; Daugherty C; King TR; Rush JE; Howard SC Pharmacotherapy; 2014 May; 34(5):427-39. PubMed ID: 24132809 [TBL] [Abstract][Full Text] [Related]
11. Glucarpidase rescue in a patient with high-dose methotrexate-induced nephrotoxicity. Tuffaha HW; Al Omar S J Oncol Pharm Pract; 2011 Jun; 17(2):136-40. PubMed ID: 19833686 [TBL] [Abstract][Full Text] [Related]
12. Glucarpidase for the Treatment of Methotrexate-Induced Renal Dysfunction and Delayed Methotrexate Excretion. Meyers PA Pediatr Blood Cancer; 2016 Feb; 63(2):364. PubMed ID: 26488216 [No Abstract] [Full Text] [Related]
13. Reply to: Glucarpidase for the Treatment of Methotrexate-Induced Renal Dysfunction and Delayed Methotrexate Excretion. Scott JR; Crews KR Pediatr Blood Cancer; 2016 Feb; 63(2):365. PubMed ID: 26488798 [No Abstract] [Full Text] [Related]
14. Practical considerations for the administration of glucarpidase in high-dose methotrexate (HDMTX) induced renal dysfunction. Widemann BC Pediatr Blood Cancer; 2015 Sep; 62(9):1512-3. PubMed ID: 25940351 [No Abstract] [Full Text] [Related]